Trademark Overview
On Wednesday, April 9, 2025, a trademark application was filed for THOXDRO with the United States Patent and Trademark Office. The USPTO has given the THOXDRO trademark a serial number of 99129316. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 9, 2025. This trademark is owned by CivicaScript, LLC. The THOXDRO trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical products for the treatment of central nervous system diseases and disorders; pharmaceutical products for the treatment of vertigo, dizziness, and lightheadedness; pharmaceutical products for the treatment of symptomatic neurogenic orthostatic hypotension; pharmaceutical products for the treatment of symptoms caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy; pharmaceutical products for the treatment of symptoms caused by Parkinson’s disease, multiple system atrophy, and pure autonomic failure
